NGIOGRAPHICALLY confirmed vasospasm is observed in more than half of the patients who suffer aneurysmal SAH and can contribute to poor outcome after aneurysm rupture. 7 One proposed mechanism that may mediate vasospasm is depletion or inactivation of NO, an endogenous vasodilator. 11, 18, 30, 38, 41 Whereas endothelium can produce NO locally, it has been demonstrated in recent studies that circulating RBCs store, transport, and release NO during conditions of local hypoxia, creating a mechanism for matching O 2 supply and demand. 21, 28, 32 Several converging lines of evidence also indicate that transfused RBCs are not "normal." 3, 9, 15, 16, 26, 29, 43 Hemoglobin in particular is known to bind and unload NO, but this binding and unloading may be altered in transfusion products. [12] [13] [14] 29, 37 Furthermore, results of recent clinical trials indicate that blood transfusions administered to critically ill patients may exacerbate poor outcome or contribute to organ ischemia. 15, 16, 26, 43 In view of these data, we postulated that patients who received a blood transfusion during their hospital course after SAH were at increased risk for vasospasm and worse outcome.
Clinical Material and Methods

Patient Population
This study includes 441 patients who were retrospectively identified from a prospective observational database containing patients treated for aneurysmal SAH at a Level I trauma center. Patients included in this study had the following characteristics: 1) Hunt and Hess 17 Grades I to V SAH; 2) at least one angiographically confirmed aneurysm; and 3) at least two angiograms available for comparison of vessel diameter. Information in the database was obtained from patient charts (operative, anesthetic, ICU, and nursing records), review of neuroimaging studies (admission and subsequent CT scans and four-vessel cerebral angiograms), clinic visits, and telephone interviews. Subarachnoid hemorrhage was confirmed radiographically on CT scans or, when scan results were negative, by lumbar puncture. The patient's admission clinical status was stratified using the Hunt and Hess grading scale, which was not increased for systemic disease or vasospasm. The severity of SAH on CT scans was evaluated using a modified Fisher grading system (CT SAH). 22, 23 Aneurysms were verified and localized using four-vessel cerebral angiography.
Management Protocol
All patients were treated according to a standard policy that included aggressive preadmission and preoperative resuscitation, early aneurysm occlusion, and aggressive prevention and treatment of intracranial hypertension and vasospasm. 22, 24, 25, 27 Patients underwent head CT scanning at admission, after aneurysm occlusion, and at least once subsequently during their hospital stay. Single-photon emission computerized tomography scans and four-vessel angiograms were obtained during the period of maximum vasospasm risk in the majority of patients; these individuals were cared for in the neurosurgery ICU with the aid of intracranial pressure and invasive hemodynamic monitoring. Volume expansion and hemodilution (normal saline infusion and albumin boluses) were initiated prophylactically in all patients. Also, each patient received nimodipine and underwent a daily transcranial Doppler ultrasonography examination to detect vasospasm. The diagnosis of vasospasm in this report required angiographic documentation. Patients in whom symptomatic vasospasm developed were treated with further volume expansion by using normal saline and albumin and induced hypertension, or angioplasty if their symptoms remained refractory. Intracranial pressure greater than 20 mm Hg was treated using medical and surgical procedures. Further details of this management protocol are described elsewhere. 22, 24, 25, 27 
Blood Transfusion
Intraoperative and ICU records were used to abstract information about the RBC transfusions given to each patient. The number and timing (intra-or postoperative) of RBC transfusions and admission (that is, preoperative) and postoperative pretransfusion hematocrit levels were recorded. The decision to transfuse RBCs depended on a patient's need and condition according to guidelines published by the National Institutes of Health Consensus Conference on perioperative blood transfusion, 2 the American College of Physicians, 1 and the American Society of Anesthesiologists. 40 Blood was transfused when there was a documented need to increase O 2 delivery in patients who were unable to meet demands through normal cardiopulmonary function or because of anemia. In general, transfusion was rarely indicated when blood hemoglobin and hematocrit were greater than 10 to 11 g/dl and 30 to 33%, respectively, and it was always indicated when hemoglobin and hematocrit were less than 6 to 7 g/dl and 18 to 21%, respectively. Between these parameters a decision to transfuse RBCs was based on the patient's clinical status and the rate and magnitude of blood loss. Red blood cells were transfused to achieve a hemo- globin level of 10 g/dl and a hematocrit of 30%. During the review period, the transfusion threshold was not altered. In addition, RBC transfusion was not used for volume expansion.
Presence of Vasospasm
In this study vasospasm was diagnosed by comparing each patient's admission four-vessel cerebral angiogram with subsequent angiograms. The majority of follow-up angiograms were obtained 7 days after aneurysm rupture. The degree of angiographically confirmed vasospasm was stratified as follows: mild, 1 to 24%; moderate, 25 to 50%; or severe, greater than 50% luminal reduction. Symptomatic vasospasm was diagnosed when there was neurological deterioration (either focal or in level of consciousness) that was associated with angiographic vasospasm.
Assessment of Outcome
Patient outcome was assessed using the Glasgow Outcome Scale 19 score at 6 months based on clinic records and telephone surveys. Outcome was classified as favorable (good outcome or moderate disability) or unfavorable (severe disability, vegetative state, or death) for statistical purposes.
Statistical Analysis
Percentages and frequency counts were used to summarize the ordinal and nominal level variables. Interval level variables are summarized as the mean Ϯ SD or as the median and range when their distributions depart substantially from normal. To assess the association between each outcome variable and each study variable cross-tabs, Pearson chi-square results and ORs were computed. Logistic regression and the adjusted ORs were used to assess the relationship between outcome variables and each main study variable, while adjusting for the effects of identified confounder and modifier variables. All uni-and multivariate analyses were performed using SAS version 8.2; SAS Institute, Inc., Cary, NC. Table 1 summarizes the clinical characteristics of the 441 patients with SAH who were included in this study. The female/male ratio was 1.8:1. One hundred fifty-nine patients (36%) had poor clinical grade SAH (Hunt and Hess Grade IV or V) and 183 (41.5%) had CT-confirmed SAH Grades 3 and 4. Most patients (230 [52.2%]) underwent aneurysm occlusion within the first 24 hours of rupture; in 42 (9.5%), however, surgery was delayed more than 10 days.
Results
Patient Characteristics
Blood Transfusion
Two hundred seventy patients (61.2%) received an RBC transfusion during their hospital stay (Table 2 ). This included 47 (17.4%) who received only intraoperative, 73 (27%) who received both intra-and postoperative, and 150 (55.6%) who received only postoperative blood transfusions. Of the patients who received blood, the overall median number of units transfused was three (range 1-31), including two postoperatively (range 1-31) and two intraoperatively (range 1-9). Table 3 lists the mean hematocrit for patients who did or did not receive intraoperative (admission hematocrit) and postoperative (pretransfusion hematocrit) RBC transfusion. Admission hematocrit was used because intraoperative pretransfusion hematocrit levels were not available in most patients. Patients who received blood, either intra-or postoperatively, had a significantly lower hematocrit than patients who did not receive blood (p = 0.0009 and p Ͻ 0.0001, respectively).
Vasospasm and Blood Transfusion
Angiographically confirmed vasospasm was present in 217 patients (49.2%). Of those, mild, moderate, or severe arterial narrowing was observed in 42.4, 31.3, and 26.3%, respectively. Among the 68 patients with both angiographic and symptomatic vasospasm, six (8.8%) had mild, 21 (30.9%) had moderate, and 41 (60.3%) had severe arterial narrowing ( Fig. 1 ). Among patients with angiographic vasospasm, 58 (26.7%) and 124 (57.2%) received intraoperative and postoperative RBC transfusions, respectively. Only 35 patients (16.1%) in whom angiographic vasospasm developed did not receive a blood transfusion during their hospital stay. For patients in whom angiographically confirmed vasospasm developed, there was a tendency to have received more blood than for those without vasospasm. Among patients in whom symptomatic vasospasm was found, 20 (28.2%) and 46 (64.8%) received intra-and postoperative RBC transfusions, respectively. There was no significant difference in the mean pretransfusion hematocrit in patients who did or did not experience angiographic or symptomatic vasospasm after receiving either intra-or postoperative transfusions (Table 4 ). The pretransfusion hematocrit values for intraoperative RBC transfusions are higher than the threshold used for transfusion because admission rather than immediate pretransfusion values are used.
The risk of angiographic vasospasm was significantly increased among patients who received postoperative RBC transfusions (OR 1.7, CI 1.17-2.48) but not in those who received intraoperative transfusions (OR 0.92, CI 0.62-1.4). This risk remained after we controlled for confounding variables including smoking history, delay to surgery, intraoperative aneurysm rupture, Hunt and Hess grade, and modified Fisher SAH grade (OR 1.68, CI 1.02-2.75; Table  5 ). When patients were stratified according to the severity of angiographic vasospasm, a trend was observed toward more severe spasm when postoperative RBC transfusion
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Outcome and Blood Transfusion
Outcome is listed in Table 1 . The likelihood of experiencing an unfavorable outcome was significantly increased among patients who received intraoperative RBC transfusions (OR 2.71, CI 1.75-4.2). Fifty-four (45%) of the patients who received intraoperative RBC transfusions also experienced intraoperative aneurysm rupture. Nevertheless, the risk of unfavorable outcome remained even after we controlled for this and other variables, including postoperative RBC transfusion, angiographic and symptomatic vasospasm, delay to surgery, smoking status, Hunt and Hess grade, and CT-confirmed SAH grade (OR 2.44, CI 1.32-4.52). The risk of unfavorable outcome was increased among patients who received postoperative RBC transfusions (OR 1.81, CI 1.21-2.71) but not after adjusting for confounding variables (OR 1.48, CI 0.83-2.63; Table 6 ). An association between angiographic (OR 0.72, CI 0.39-1.33) or symptomatic vasospasm (OR 0.8, CI 0.36-1.77) and outcome was not observed.
Discussion
In this study we examined the association between blood transfusion, vasospasm, and outcome in 441 patients with aneurysmal SAH. An increased risk of angiographically confirmed vasospasm, even after we controlled for confounding factors such as Hunt and Hess grade, SAH grade, delay to surgery, age, sex, smoking status, and intraoperative aneurysm rupture, was observed among patients who received a postoperative RBC transfusion. Patients who received an intraoperative RBC transfusion were at increased risk for worse outcome after we controlled for the same confounding variables. These findings are consistent with recent observations demonstrating that transfusion products may exacerbate ischemia or induce vasoconstriction, in part through altered NO metabolism, 3, 9, 21, 26, 28, 33 and are associated with worse outcome in patients who have been admitted to a critical care unit. 15, 16, 43 
Methodological Considerations
To determine how RBC transfusion influenced vasospasm and outcome we retrospectively queried a prospective observational database. There are limitations to this kind of analysis. First, we cannot determine the precise time a postoperative transfusion was administered relative to an angiogram. Second, we do not know the exact reason for an RBC transfusion, which conceivably may have predisposed the patient to vasospasm. Nevertheless, the reason a patient received a transfusion is unlikely to be important for several reasons. During the time period in which data were accrued, all patients were treated according to a standard protocol and saline or albumin, but not blood, was used for volume expansion. The significant differences in hematocrit between patients who did or did not receive RBC transfusion indicate that hematological factors, that is, anemia, were probably important when deciding who would receive transfusions postoperatively. Whether this is true for intraoperative RBC transfusions is uncertain because intraoperative hematocrit and hemoglobin values were not available. Nevertheless, we controlled for a large number of potentially confounding variables in multivariate analysis that should in large part account for any influence associated with why an RBC transfusion was given. Despite these limitations the results are provocative; they indicate either that the "trigger point" for transfusion among patients with SAH needs to be reevaluated or that "normovolemic anemia" should be more readily tolerated.
Transfusion and Vasospasm
Our results demonstrate that post-but not intraoperative RBC transfusion was associated with a greater risk of angiographically confirmed vasospasm. There was a weaker association between postoperative RBC transfusions and symptomatic vasospasm. This is perhaps not surprising because not every patient with angiographic vasospasm becomes symptomatic, and factors other than vessel caliber can influence whether delayed ischemia develops. 7 Furthermore, all patients received nimodipine and volume ex- pansion; these preventive strategies appear to reduce the incidence of delayed ischemia but not of angiographic vasospasm. 18 A potential explanation for the different incidence of angiographically confirmed vasospasm among patients receiving intra-or postoperative RBC transfusion is the timing of the transfusion. For example, more than half of our patients underwent surgery within 24 hours of aneurysm rupture, a period that precedes the peak time for vasospasm in humans. 42 During this early post-SAH phase, cerebral vessels demonstrate impaired autoregulation and may not be responsive to the dilatory actions of NO. Therefore, depletion of functional NO associated with RBC transfusion may not significantly affect these vessels. Along the same lines, Schwartz, et al., 35 demonstrated a biphasic response of CBF recovery to an NO synthase inhibitor in a rat model of SAH. During the first 15 to 30 minutes after SAH, cerebral vessels were unresponsive to the NO synthase inhibitor, demonstrating no change in CBF recovery. Nevertheless, 60 minutes after SAH, CBF recovery was impaired. Studies in humans confirm that cerebrovascular activity is also impaired after SAH. For example, Dernbach, et al., 6 demonstrated that CO 2 reactivity and autoregulation were decreased in cerebral vessels during the first 7 days after aneurysm rupture. Although blood transfused during the early post-SAH phase, including intraoperative RBC transfusions, may dilute the NO pool, this action may have a limited effect on cerebral blood vessels because autoregulation is impaired and therefore is not associated with vasospasm. By contrast, several days after SAH, if vessel autoregulation is restored or partially restored, blood vessels may become more responsive to the altered NO pool because of RBC transfusion. Further studies are needed to resolve this question.
Transfusion and Outcome
Despite advances in diagnostic and management methods, outcome remains poor after SAH. 4, 8, 18, 25, 34 Our study raises the interesting possibility that a treatment considered beneficial, that is, blood transfusion, also may be associated with or exacerbate poor outcome after SAH. This finding is consistent with recent observations from a large prospective observational study and a randomized clinical trial in which it was concluded that blood administered to patients in a critical care unit may have been an independent variable for poor outcome and major organ failure. 15, 43 For example, in the only randomized trial examining transfusion triggers in critical care, Hebert, et al., 16 observed reduced mortality rates in patients treated when the hemoglobin was 7 g/ dl rather than the more conventional "trigger" of 10 g/dl. This decrease was most significant in less acutely ill patients, a group that would include many good-grade patients with SAH.
We observed that intra-but not postoperative RBC transfusion was associated with an increased risk of worse outcome after we controlled for confounding variables. Unadjusted ORs, however, demonstrated an association between poor outcome and postoperative RBC transfusion. Could these results represent an epiphenomenon? We think this
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Vasospasm and red blood cell transfusion 5 is unlikely because after controlling for intraoperative aneurysm rupture, which may reflect intraoperative hypotension, anemia, cerebral edema, and retractor injury among other variables, and is a known risk factor for poor outcome, the relationship between intraoperative RBC transfusion and unfavorable outcome remained statistically significant. In addition, after controlling for other variables (such as clinical grade and CT grade of SAH) that are the most significant predictors of outcome, intraoperative RBC transfusion was still associated with poor outcome. The absence of an association between postoperative RBC transfusion and poor outcome may weaken any true relationship between intraoperative transfusions and outcome. We do not think this is likely because we observed a strong trend between worse outcome and greater number of transfused units in multivariate analysis. It is also conceivable that effective vasospasm management and advances in critical care may have negated any modest but real association between outcome and postoperative RBC transfusion. 22, 25, 27 In addition, care was withdrawn in many poor-grade patients or they died early in their clinical course, and some of these patients who subsequently experienced a poor outcome did not receive an RBC transfusion. This may explain why an association between postoperative RBC transfusion and unfavorable outcome was observed using unadjusted but not adjusted ORs.
Deleterious Effects of Blood Transfusion: Potential Mechanisms
Several potential mechanisms may explain the association between vasospasm and RBC transfusion. First, the endogenous vasodilator NO is known to affect vasoconstriction of cerebral vessels in vasospasm. 11, 20, 30, 35, 41, 44 Several studies indicate that NO is not only produced on demand from the vessel wall, but that it is also stored and transported within the cytosol of erythrocytes through an S-nitrosothiol-cysteine bond near the membrane surface. The NO then is transferred to the RBC surface during transport through areas of decreased arterial O 2 tension, inducing its release and resulting in vasodilation. 21, 32, 37 It has been proposed that transfused RBCs may be depleted of this stored NO, resulting in dilution of the active vasodilatory agent when transfusion occurs. 21, 28 If this concept is true, dilution of RBC-associated NO by RBC transfusion may blunt the cerebral vessel's vasodilatory response and enhance vasospasm. Second, in several studies researchers suggest an inflammatory component to cerebral vasospasm. 5 Stored RBCs are known to have potentially adverse proinflammatory effects or to induce immunodysfunction. 29 Finally, after a traumatic event including surgery or a stroke heme, the iron-bearing O 2 carrying core of hemoglobin can be liberated. In large concentrations this heme can limit the function of the Slo1 BK channel, a cell membrane protein that is important for blood vessel relaxation. 39 Whether this is true of transfused RBC has yet to be determined.
Similar mechanisms may explain the association between transfusion and poor outcome. First, if NO depletion due to RBC transfusion is a true phenomenon, it is possible that intraoperative cerebral vasoconstriction may adversely affect responsive vessels in the ischemic penumbra or under a retractor blade at the time of surgery, thus aggravating postoperative recovery in the absence of delayed vasospasm. Second, transfused RBCs have reduced deformability that can be associated with microvascular obstruction, 3,9,31 thus leading to ischemia even when vasospasm is absent. Similarly, alterations in 2,3-diphosphoglycerate in stored RBCs may alter hemoglobin O 2 binding or release, causing local tissue hypoxia. Third, transfused RBCs contain iron; this additional iron in its ferrous form may exacerbate oxidative stress, 10 thus contributing to worse ischemic injury. Finally, cytokines such as interleukin-1, -6, and -8 can be generated during RBC storage, 36 which may exacerbate cerebral ischemia or edema. Along these lines, stored RBCs are postulated to provoke neutrophilic and in particular polymorphonuclear cytotoxicity; these are key cell mediators of multiple organ failure. 29 These various findings may help explain why outcome was worse in our patients and why RBC transfusions can also induce splanchnic ischemia in critically ill patients 26 because the transfusions may not consistently improve tissue oxygenation.
No matter which mechanism is associated with the potential deleterious effects of RBC transfusion after SAH, the results of our study are provocative and indicate that blood transfusion may exacerbate vasospasm and contribute to poor patient outcome. These findings are consistent with recent clinical trials of RBC transfusion in critical care, which indicate that increased organ dysfunction and worse patient outcome are associated with liberal rather than restrictive RBC transfusion strategies. 15, 43 Our findings are derived from retrospective analysis and so are preliminary; they indicate, however, that further research focusing on the potential negative effects of RBC transfusion in patients after SAH should be conducted. Furthermore, physicians should be cautioned against using the "10/30" hemoglobin and hematocrit trigger for administering RBC transfusions in all patients or be more tolerant of normovolemic anemia. Unless inadequate tissue oxygenation underlies the patient's disease, a more conservative RBC transfusion strategy may be reasonable for many patients after SAH.
